Quick Takeaways
- Allen Baharaff filed SCHEDULE 13G/A for Galmed Pharmaceuticals Ltd. Ordinary shares, NIS 1.80 par value per share (GLMD).
- Disclosed ownership: 2.6%.
- Date of event: 31 Dec 2024.
Allen Baharaff - 31 Dec 2024 SCHEDULE 13G/A Report for Galmed Pharmaceuticals Ltd. Ordinary shares, NIS 1.80 par value per share (GLMD)
- Filing Manager
- Allen Baharaff
- Reporting Manager
- Allen Baharaff
- Symbol
- GLMD
- Shares outstanding
- 1,697,231 shares
- Disclosed Ownership
- 44,128 shares
- Ownership
- 2.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 18 Feb 2025, 16:15:05 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Allen Baharaff disclosed 2.6% ownership in Galmed Pharmaceuticals Ltd. Ordinary shares, NIS 1.80 par value per share (GLMD) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Feb 2025, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Allen Baharaff | 2.6% | 44,128 | 44,128 | 0 | /s/ Allen Baharaff | Allen Baharaff |